Medicine & Life Sciences
Gram-Positive Bacteria
100%
Gram-Negative Bacteria
91%
Nanoparticles
80%
Nitric Oxide
73%
Technology
59%
Community-Acquired Infections
20%
Streptococcus pyogenes
18%
Acinetobacter baumannii
18%
Soft Tissue Infections
18%
Enterococcus faecalis
17%
Klebsiella pneumoniae
16%
Anti-Infective Agents
15%
Methicillin-Resistant Staphylococcus aureus
15%
Microbial Drug Resistance
15%
Pseudomonas aeruginosa
14%
Abscess
14%
Escherichia coli
10%
Bacteria
10%
Anti-Bacterial Agents
9%
Morbidity
8%
Skin
8%
Mortality
7%
Wounds and Injuries
7%
In Vitro Techniques
6%
Therapeutics
2%
Agriculture & Biology
nanoparticles
89%
nitric oxide
81%
bacteria
50%
anti-infective agents
35%
Acinetobacter baumannii
20%
Streptococcus pyogenes
20%
abscess
19%
methicillin-resistant Staphylococcus aureus
19%
Klebsiella pneumoniae
17%
Enterococcus faecalis
16%
animal injuries
16%
infection
16%
morbidity
15%
Pseudomonas aeruginosa
14%
antibiotic resistance
14%
therapeutics
11%
skin (animal)
11%
antibiotics
11%
microorganisms
9%
Escherichia coli
9%
mice
8%
tissues
6%